SHARE PURCHASE AGREEMENTShare Purchase Agreement • June 25th, 2021 • Liminal BioSciences Inc. • Pharmaceutical preparations • Ontario
Contract Type FiledJune 25th, 2021 Company Industry JurisdictionShare Purchase Agreement dated June 22, 2021 among, Kedrion S.p.A. ("Purchaser" or "Kedrion") or a designee thereof as may be provided in accordance with Section 15.7 of this Agreement, and Liminal BioSciences Inc. ("Seller").
SHARE PURCHASE AGREEMENT among Kedrion S.p.A. as Purchaser -and- Liminal BioSciences Inc. as Seller dated May 14, 2021Share Purchase Agreement • May 21st, 2021 • Liminal BioSciences Inc. • Pharmaceutical preparations • Ontario
Contract Type FiledMay 21st, 2021 Company Industry JurisdictionWHEREAS Seller is the beneficial and registered owner of one hundred percent (100%) of the issued and outstanding shares of Prometic Plasma Resources Inc. (“PPR Canada”) and Prometic Plasma Resources (USA) Inc. (“PPR USA” and together with PPR Canada, the ”Corporations”) and the beneficial and registered owner of one hundred percent (100%) of the issued and outstanding shares of Prometic Biotherapeutics Inc. (“PBT”) and Prometic Bioproduction Inc. (“PBP”, and together with PBT, the ”Ryplazim Targets”);